Review: Helicobacter pylori and non-malignant upper gastrointestinal diseases. 2019

Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
Division of Gastroenterology, Rabin Medical Center, Petah Tikva, and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

This review covers recent publications investigating the relationship between Helicobacter pylori infection and gastroesophageal reflux disease, Barrett's esophagus, eosinophilic esophagitis, peptic ulcer disease (PUD), H pylori gastritis, and functional dyspepsia. In the area of gastroesophageal reflux disease, new data suggest that reflux may have a role in the transmission of H pylori infection. In addition to several observational studies, data on alterations in esophageal physiology in patients with H pylori infection are presented. Further evidence for the inverse relationship between H pylori infection and Barrett's esophagus is available in the form of a meta-analysis from the North American Barrett's and Esophageal Carcinoma Consortium. The relationship between H pylori infection and eosinophilic esophagitis remains uncertain. Although new data do not indicate a significantly lower prevalence of H pylori among patients with eosinophilic esophagitis, a meta-analysis showed a 37% reduced risk of eosinophilic esophagitis among H pylori-infected patients. Novel data are presented on the genetic variability of bacterial virulence factors and their relationship with PUD. We also report data on plasma biomarkers, which may detect progression to gastric cancer in H pylori-associated PUD. A new meta-analysis was published, which assessed the risk of PUD in low-dose aspirin users with H pylori infection. Finally, we report on the ongoing attempts to stratify patients with gastritis using endoscopic methods when compared to standard biopsy examination.

UI MeSH Term Description Entries
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter

Related Publications

Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
September 2016, Helicobacter,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
September 2020, Helicobacter,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
September 2018, Helicobacter,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
October 2007, Helicobacter,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
October 2008, Helicobacter,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
October 2006, Helicobacter,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
September 2009, Helicobacter,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
January 2005, Helicobacter,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
September 1997, Journal of experimental & clinical cancer research : CR,
Doron Boltin, and Yaron Niv, and Kerstin Schütte, and Christian Schulz
January 2019, Advances in experimental medicine and biology,
Copied contents to your clipboard!